Clinical
RSSArticles
-
Study: No Connection Between Cranberry Products, Fewer Urinary Tract Infections
The authors concluded that among older women who are nursing home residents, administration of cranberry capsules vs. placebo was of no benefit in preventing bacteriuria plus pyuria over one year.
-
Growing Evidence of Link Between Cognitive Dysfunction, Androgen Deprivation Therapy
The authors suggested androgen deprivation therapy in the treatment of prostate cancer may be associated with an increased risk of dementia.
-
CDC Calls for Two-shot HPV Regimen
Recent studies have shown if the first shot is administered before age 15, two shots confer immunity.
-
New Research Supports Safety of Receiving Vital Vaccination During Pregnancy
Infants exposed to combined tetanus, diphtheria, and acellular pertussis vaccinations were no more likely to develop structural birth defects, including microcephaly, than offspring of unvaccinated mothers.
-
Why Do the Beats Keep Changing?
What clinical situation commonly is associated with arrhythmias such as the one shown in this figure?
-
Adalimumab-atto Injection (Amjevita)
Adalimumab-atto provides an alternative to adalimumab for multiple chronic inflammatory conditions.
-
Optimal Blood Pressure in Patients Presenting with Aortic Stenosis
A post-hoc analysis of patients suffering from mild to moderate aortic stenosis in a study of low-density lipoprotein cholesterol lowering showed that the optimal blood pressure for the best survival was 130-139/70-90 mmHg.
-
What Should You Tell Your Patients About Sleep Apnea, CPAP, and Heart Disease?
In this large, multicenter, randomized, controlled trial, continuous positive airway pressure did not reduce incident cardiovascular events compared with usual care, but did reduce snoring and daytime sleepiness and improved health-related quality of life and mood.
-
Is There a Link Between Hormonal Contraception and Depression?
Recent study results not as clear-cut as they seem -
What Do Gay and Bisexual Men Without HIV Know About PrEP?
Studies have shown that pre-exposure prophylaxis, or PrEP, reduces HIV incidence by 92% in HIV-negative people who are at high risk for HIV, including men who have sex with men.